Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.71 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.71 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 3/20 | 0.43 |
| ▸ | FNTA | P49354 | 2/20 | 0.43 |
| ▸ | FNTB | P49356 | 2/20 | 0.43 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11785322 | 1.00 | ALDH1A1 (0.71) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL1070989 | 1.00 | ALDH1A1 (0.71) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL13288245 | 0.98 | ALDH1A1 (0.69) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL29586651 | 0.88 | ALDH1A1 (0.54) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL28410357 | 0.86 | ALDH1A1 (0.71) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL30342059 | 0.85 | ALDH1A1 (0.51) | ALDH1A1ALOX15TRPV1FNTAFNTB | |
| SCHEMBL10613495 | 0.84 | ALDH1A1 (0.73) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL10613500 | 0.84 | ALDH1A1 (0.73) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL2560936 | 0.83 | ALDH1A1 (0.72) | ALDH1A1ALOX15PTPN1TRPV1FNTA | |
| SCHEMBL2560933 | 0.83 | ALDH1A1 (0.72) | ALDH1A1ALOX15PTPN1TRPV1FNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6284910-B1 | FARNESYL TRANSFERASE INHIBITORS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2001-09-04 | — | — | US | claimed |
| CN-111269121-B | Purification method of 8-oxo-3, 7-dimethyl-2, 6-octadienyl carboxylate compound | 广州巨元生化有限公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-1879902-B1 | COMPOSITION COMPRISING ONE OR MORE LYCOPHYLL DERIVATIVES | CARDAX PHARMA INC (US) | 2020-01-08 | — | — | EP | disclosed |
| EP-1797953-B1 | PROCESS FOR PRODUCING OXYGENIC COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009104605-A1 | NOVEL INTERMEDIATE FOR SYNTHESIS OF ASCOFRANONE HAVING VARIOUS PHYSIOLOGICAL ACTIVITIES, AND NOVEL SHORTENED TOTAL SYNTHESIS METHOD FOR ASCOFRANONE USING THE SAME | アリジェン製薬株式会社 (JP) | 2009-08-27 | — | — | WO | disclosed |
| US-7435861-B2 | carotenes or xanthophylls, used as free radical scavengers; cytoprotective agents; oxidation resistance | CARDAX PHARMACEUTICALS, INC. (US) | 2008-10-14 | — | — | US | disclosed |
| US-20080221377-A1 | Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates | CARDAX PHARMACEUTICALS, INC. | 2008-09-11 | — | — | US | disclosed |
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1879902-A2 | METHODS FOR SYNTHESIS OF CAROTENOIDS, INCLUDING ANALOGS, DERIVATIVES, AND SYNTHETIC AND BIOLOGICAL INTERMEDIATES | Hawaii Biotech, Inc. (US) | 2008-01-23 | — | — | EP | disclosed |
| WO-2007147163-A2 | COMPOSITIONS COMPRISING CAROTENOID ANALOGS OR DERIVATIVES AND METHODS FOR SYNTHESIS | CARDAX PHARMACEUTICALS, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| EP-0412551-A2 | Process for producing alpha, beta-unsaturated aldehyde | KURARAY CO., LTD. (JP) | 1991-02-13 | — | — | EP | disclosed |
| US-4947001-A | Halogenating hydroxysulfone salt | KURARAY COMPANY, LTD. (JP) | 1990-08-07 | — | — | US | disclosed |
| EP-0187259-B1 | PROCESS FOR PRODUCING VITAMIN A OR ITS CARBOXYLIC ACID ESTERS, AND INTERMEDIATE COMPOUNDS USEFUL FOR THE PROCESS | KURARAY CO., LTD. (JP) | 1990-06-13 | — | — | EP | disclosed |
| EP-0348813-A2 | Process for producing halogenated sulfone | KURARAY CO., LTD. (JP) | 1990-01-03 | — | — | EP | disclosed |
| US-4876400-A | DESULFONATION | KURARAY CO., LTD. (JP) | 1989-10-24 | — | — | US | disclosed |
| US-4825006-A | A-ARYLSULFONYL- | KURARAY CO., LTD. (JP) | 1989-04-25 | — | — | US | disclosed |
| US-4745229-A | OXIDATION, DECHLORINATION | KURARAY COMPANY LTD. (JP) | 1988-05-17 | — | — | US | disclosed |
| EP-0234496-A2 | Process for preparing alpha, beta-unsaturated aldehydes | Kuraray Co., Ltd. (JP) | 1987-09-02 | — | — | EP | disclosed |
| EP-0187259-A2 | Process for producing vitamin A or its carboxylic acid esters, and intermediate compounds useful for the process | KURARAY CO., LTD. (JP) | 1986-07-16 | — | — | EP | disclosed |
| US-3931257-A | ANTIINFLAMMATORY, ANTIALLERGY | HOFFMANN-LA ROCHE INC. (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064898-A1 | Method for Producing Oxygen-Containing Compound | AOC2, AOX1, CAT | ALDH1A1 36/4885ALOX15 312/4885PTPN1 4806/4885 |
| US-20080221377-A1 | Methods for synthesis of carotenoids, including analogs, derivatives, and synthetic and biological intermediates | HCCS, SQOR, CBR3 | ALDH1A1 1671/4885ALOX15 38/4885PTPN1 3786/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.